Most individuals w/ certain kinds of immunocompromise who have received a bivalent C19 vaccine may receive a single additional dose of a bivalent C19 vaccine at least 2 months following a dose of a bivalent C19 vaccine, and additional doses may be administered at the discretion of, and at intervals determined by, their healthcare provider. However,for immunocompromised individuals 6 months through 4 yrs old, eligibility for additional doses will depend on the vaccine previously received.

3/4